Pilot Study of NKG2D-Ligand Targeted CAR-NK Cells in Patients With Metastatic Solid Tumours
NCT03415100
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumours
Interventions
BIOLOGICAL:
CAR-NK cells targeting NKG2D ligands
Sponsor
The Third Affiliated Hospital of Guangzhou Medical University